With Wyeth, Pfizer Becomes The Second-largest Multinational Pharma In India
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth India had revenues of $76 million in 2008 from products such as Enbrel, Rapamune, Prevenar and Tygacil.